Naomi Chambers

Naomi Chambers i

University of Manchester - Manchester / United Kingdom
Medical and Health Sciences / Health Sciences
AD Scientific Index ID: 1053185
person_outline Naomi Chambers's MOST POPULAR ARTICLES
1-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 397 (10285), 1637-1645, 2021786*2021
2-) RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19P Horby, WS Lim, JR Emberson, M Mafham, JL Bell, L Linsell, N Staplin, ...N Engl J Med 384 (8), 693-704, 2021635*2021
3-) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 399 (10325), 665-676, 2022489*2022
4-) Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialRECOVERY Collaborative GroupLancet (London, England) 399 (10320), 143, 20222942022
5-) The role of corporate governance and boards in organisational performanceN Chambers, C CornforthConnecting knowledge and performance in public services: From knowing to …, 2010872010